Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Accenture
Chubb
Healthtrust
Argus Health
QuintilesIMS

Make Better Decisions, Faster

Do you need a custom analysis, patent litigation support, or due diligence assistance? Contact Us

Short-term or Annual Plans • Discounts for Multiple Users/Years • Upgrade Anytime

82% Pick This

Pharmaceutical Drugs

$8,000/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

$3,000/year

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

$6,000/year

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

$6,000/year

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

$4,000/year

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

$3,000/year

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

82% Pick This

Pharmaceutical Drugs

$1,000/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries, Regulatory Protections and Exclusivities
  • Anticipate Generic Entry
  • Loss-of-Exclusivity Dates, Paragraph IV Challenges, Tentative Approvals, Authorized Generics, and more…
  • Find Commercial Opportunities
  • Single Source Off-Patent Drugs, Search Patents by Dosage Form / Therapeutic Class
  • Drug Sourcing
  • API Vendors, Finished Product Suppliers, First Generic Entrants

 

Biologic Drugs

$400/monthly

  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Finished Product Suppliers
  • Manufacturers

 

Drugs In Development

$750/monthly

  • Drug Candidates in Phase I-III Clinical Trials
  • US & International Patents
  • Active and Expired Patents in 134 Countries
  • Clinical Trials
  • API Vendors

US Drug Patent Litigation

$750/monthly

  • US District Court Cases
  • Patent Infringement, Contract Disputes, Antitrust, etc.
  • Patent Trial and Appeal Board
  • PTAB inter partes review, post-grant review

US Drug Prices

$500/monthly

  • Brand vs. Generic Drug Price Gap
  • Find generic entry opportunities
  • Average Pharmacy Cost
  • Set reasonable launch prices
  • Best-Available Price
  • See price ranges

US Top Drug Sales

$400/monthly

  • Annual Gross Revenues & Units Sold
  • Prescription Payment Methods
  • Self-Paid, Private Insurance, Medicaid, etc.
  • Pharmacy Locations & Types
  • Mail-order, Drugstore, in-Clinic, etc.

DrugPatentWatch cited by CNN, NEJM, Nature Journals, and more …

Clients in 66 Countries